Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Wegovy (Semaglutide Injection) Wegovy is the weight-loss-focused version of semaglutide, offering a reliable solution for those with a BMI of 30 or higher, or 27 with weight-related health conditions
Keep in mind that PlushCares therapists do not prescribe medication
23) Viatris 2022 Revenue: In 2022, Viatris had an annual revenue of $16.22 billion, an 8.96 percent decrease from $17.81 billion in 2021
however, following Wegovy's 2024 cardiovascular risk reduction indication, Medicare Part D plans may cover Wegovy when prescribed specifically for this cardiovascular indication in eligible patients
Others benefit from the larger A1C and weight changes of the injectable
Showing 5 PubMed records
US$ 20.87
US$ 26.09
US$ 26.00
US$ 21.18
US$ 28.30
US$ 23.10
